{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:05:33Z","timestamp":1759482333896},"reference-count":91,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,1,12]],"date-time":"2005-01-12T00:00:00Z","timestamp":1105488000000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hemodialysis International"],"published-print":{"date-parts":[[2005,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Anemia is a common complication of chronic kidney disease, particularly in patients who are on dialysis. The use of recombinant human erythropoietin has led to the eradication of severe anemia in the dialysis population. Correction of anemia in these patients has been associated with better quality of life and clinical outcomes. Some hemodialysis patients have anemia that either is relatively refractory to epoetin therapy or requires very high doses of epoetin (i.e., hyporesponsiveness), despite having adequate iron stores, and are thus unable to achieve or maintain target hemoglobin levels. Several pharmacologic agents have been studied for effects on improving response to epoetin, either to counter hyporesponsiveness or simply to reduce epoetin use for purely economic reasons. This review examines the available literature regarding the efficacy of these potential pharmacologic adjuvants to epoetin in the treatment of anemia in patients on maintenance hemodialysis, with special emphasis on androgens, vitamin C (ascorbic acid), and <jats:sc>l<\/jats:sc>\u2010carnitine. A review of published guidelines and recommendations for use of these agents in hemodialysis patients is provided.<\/jats:p>","DOI":"10.1111\/j.1492-7535.2005.01113.x","type":"journal-article","created":{"date-parts":[[2005,1,12]],"date-time":"2005-01-12T13:28:59Z","timestamp":1105536539000},"page":"7-22","source":"Crossref","is-referenced-by-count":14,"title":["Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis"],"prefix":"10.1111","volume":"9","author":[{"given":"Jeffrey S.","family":"Berns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Mosenkis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,1,12]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1985.109"},{"issue":"4","key":"e_1_2_9_3_2","first-page":"345","article-title":"Impact of hematocrit on morbidity and mortality","volume":"20","author":"Collins AJ","year":"2000","journal-title":"Semin Nephrol."},{"issue":"11","key":"e_1_2_9_4_2","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1681\/ASN.V12112465","article-title":"Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36% to 39%","volume":"12","author":"Collins AJ","year":"2001","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"e_1_2_9_5_2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1681\/ASN.V71140","article-title":"Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: A prospective study","volume":"7","author":"Teruel JL","year":"1996","journal-title":"J Am Soc Nephrol."},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008306301255"},{"key":"e_1_2_9_7_2","first-page":"232","article-title":"Androgens for the treatment of anemia in peritoneal dialysis patients","volume":"14","author":"Navarro JF","year":"1998","journal-title":"Adv Perit Dial."},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00271.x"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80246-0"},{"issue":"5","key":"e_1_2_9_10_2","first-page":"264","article-title":"A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis","volume":"37","author":"Berns JS","year":"1992","journal-title":"Clin Nephrol."},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90307-3"},{"issue":"1","key":"e_1_2_9_12_2","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/S0272-6386(01)70008-X","article-title":"IV. NKF\u2010K\/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000","volume":"37","year":"2001","journal-title":"Am J Kidney Dis."},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1026"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365599609181318"},{"issue":"10","key":"e_1_2_9_15_2","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1681\/ASN.V3101660","article-title":"Cost implications to Medicare of recombinant erythropoietin therapy for the anemia of end\u2010stage renal disease","volume":"3","author":"Powe NR","year":"1993","journal-title":"J Am Soc Nephrol."},{"issue":"30","key":"e_1_2_9_16_2","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1016\/S0021-9258(18)67014-0","article-title":"The effects of ascorbic acid on the intracellular metabolism of iron and ferritin","volume":"261","author":"Bridges KR","year":"1986","journal-title":"J Biol Chem."},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1971.tb07024.x"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1959.tb04020.x"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.220.13.1697"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-197201000-00068"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.185"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050668"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/10.supp6.44"},{"issue":"12","key":"e_1_2_9_24_2","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1681\/ASN.V1121289","article-title":"Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal","volume":"1","author":"Costello JF","year":"1991","journal-title":"J Am Soc Nephrol."},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh1027"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/13.11.2867"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00479.x"},{"issue":"6","key":"e_1_2_9_28_2","first-page":"444","article-title":"Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: A clinical trial","volume":"13","author":"Giancaspro V","year":"2000","journal-title":"J Nephrol."},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.2002.06888.x"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-120021157"},{"issue":"5","key":"e_1_2_9_31_2","first-page":"703","article-title":"Comparative study of intravenous ascorbic acid versus low\u2010dose desferroxamine in patients on hemodialysis with hyperferritinemia","volume":"16","author":"Deira J","year":"2003","journal-title":"J Nephrol."},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00356-1"},{"issue":"4","key":"e_1_2_9_33_2","first-page":"276","article-title":"Effectiveness of erythropoiesis on supervised intradialytic oral iron and vitamin C therapy is correlated with Kt\/V and patient weight","volume":"53","author":"Tovbin D","year":"2000","journal-title":"Clin Nephrol."},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-3-344"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1159\/000183353"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/6.6.440"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.2001.025006430.x"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00419-0"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.25.15656"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00365-2"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)90422-1"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1990.289"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.1992.tb00119.x"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.2001.00055.x"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00113-6"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1987.271"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188942"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-100100853"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90439-5"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69093.x"},{"key":"e_1_2_9_51_2","first-page":"302","article-title":"Endocrine\u2010metabolic effects of l\u2010carnitine in patients on regular dialysis treatment","volume":"19","author":"Albertazzi A","year":"1983","journal-title":"Proc Eur Dial Transplant Assoc."},{"key":"e_1_2_9_52_2","first-page":"1042","article-title":"Long\u2010term 1\u2010carnitine treatment of chronic anaemia of patients with end\u2010stage renal failure","volume":"31","author":"Trovato GM","year":"1982","journal-title":"Clin Ther Res."},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/38.4.523"},{"key":"e_1_2_9_54_2","first-page":"621","article-title":"Effects of l\u2010carnitine on chronic anemia and adenosine triphosphate concentration in hemo\u2010 dialyzed patients","volume":"41","author":"Donatelli M","year":"1987","journal-title":"Curr Ther Res."},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/38.4.532"},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365518509160992"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186237"},{"key":"e_1_2_9_58_2","doi-asserted-by":"publisher","DOI":"10.1159\/000187080"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1159\/000189060"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90147-X"},{"issue":"3","key":"e_1_2_9_61_2","first-page":"209","article-title":"Body composition and long\u2010term levo\u2010carnitine supplementation","volume":"149","author":"Trovato GM","year":"1998","journal-title":"Clin Ter."},{"key":"e_1_2_9_62_2","first-page":"498","article-title":"Effects of L\u2010carnitine on anemia in aged hemodialysis patients treated with recombinant human erythropoietin: A pilot study","volume":"27","author":"Caruso U","year":"1998","journal-title":"Dial Transplant."},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1159\/000014474"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1159\/000045993"},{"key":"e_1_2_9_65_2","doi-asserted-by":"publisher","DOI":"10.1159\/000078399"},{"issue":"3","key":"e_1_2_9_66_2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1681\/ASN.V133708","article-title":"Effects of l\u2010carnitine supplementation in maintenance hemo\u2010 dialysis patients: A systematic review","volume":"13","author":"Hurot JM","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.255.9.1137b"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-9877(82)90060-3"},{"key":"e_1_2_9_69_2","first-page":"177","article-title":"Consensus Group statement: Role of l\u2010carnitine in treating renal dialysis patients","volume":"23","year":"1994","journal-title":"Dial Transplant."},{"key":"e_1_2_9_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00110-0"},{"issue":"5","key":"e_1_2_9_71_2","first-page":"28","article-title":"L\u2010Carnitine use in dialysis patients: Is national coverage for supplementation justified? What were CMS regulators thinking\u2014or were they?","volume":"17","author":"Steinman TI","year":"2003","journal-title":"Nephrol News Issues."},{"key":"e_1_2_9_72_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2000.35s1"},{"key":"e_1_2_9_73_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199500252-00016"},{"key":"e_1_2_9_74_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199500252-00017"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655999750016113"},{"key":"e_1_2_9_76_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000131523.17045.56"},{"key":"e_1_2_9_77_2","doi-asserted-by":"publisher","DOI":"10.1161\/hq1101.098486"},{"key":"e_1_2_9_78_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000080895.05158.8B"},{"key":"e_1_2_9_79_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200106283442601"},{"issue":"4","key":"e_1_2_9_80_2","first-page":"422","article-title":"Decreased erythropoietin requirements in maintenance hemodialysis patients with statin therapy","volume":"49","author":"Sirken G","year":"2003","journal-title":"ASAIO J."},{"key":"e_1_2_9_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90116-5"},{"key":"e_1_2_9_82_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188758"},{"issue":"5","key":"e_1_2_9_83_2","first-page":"290","article-title":"Is folate supplementation necessary in hemodialysis patients on erythropoietin therapy","volume":"38","author":"Ono K","year":"1992","journal-title":"Clin Nephrol."},{"key":"e_1_2_9_84_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1996.19"},{"key":"e_1_2_9_85_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.11.2312"},{"key":"e_1_2_9_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004670050003"},{"key":"e_1_2_9_87_2","doi-asserted-by":"publisher","DOI":"10.1159\/000183516"},{"issue":"2","key":"e_1_2_9_88_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ajcn\/39.2.223","article-title":"Lack of effect of vitamin E therapy on the anemia of patients receiving hemodialysis","volume":"39","author":"Sinsakul V","year":"1984","journal-title":"Am J Clin Nutr."},{"key":"e_1_2_9_89_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.2003.07214.x"},{"key":"e_1_2_9_90_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.34919"},{"issue":"5","key":"e_1_2_9_91_2","first-page":"558","article-title":"Effects of a vitamin E\u2010bonded membrane and of glutathione on anemia and erythropoietin requirements in hemodialysis patients","volume":"15","author":"Usberti M","year":"2002","journal-title":"J Nephrol."},{"key":"e_1_2_9_92_2","doi-asserted-by":"publisher","DOI":"10.1081\/BIO-120020177"}],"container-title":["Hemodialysis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1492-7535.2005.01113.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1492-7535.2005.01113.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T06:12:42Z","timestamp":1697350362000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1492-7535.2005.01113.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["10.1111\/j.1492-7535.2005.01113.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1492-7535.2005.01113.x","archive":["Portico"],"relation":{},"ISSN":["1492-7535","1542-4758"],"issn-type":[{"value":"1492-7535","type":"print"},{"value":"1542-4758","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}